Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?

S Mirzaei, A Zarrabi, F Hashemi, A Zabolian, H Saleki… - Cancer Letters, 2021 - Elsevier
The nuclear factor-kappaB (NF-κB) signaling pathway is considered as a potential
therapeutic target in cancer therapy. It has been well established that transcription factor NF …

Molecular mechanisms of cancer development in obesity

MJ Khandekar, P Cohen, BM Spiegelman - Nature Reviews Cancer, 2011 - nature.com
The increasing incidence of obesity and its co-morbid conditions poses a great challenge to
global health. In addition to cardiovascular disease and diabetes, epidemiological data …

Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment

P Basnet, N Skalko-Basnet - Molecules, 2011 - mdpi.com
Oxidative damage and inflammation have been pointed out in preclinical studies as the root
cause of cancer and other chronic diseases such as diabetes, hypertension, Alzheimer's …

Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer

JJ Farrell, L Zhang, H Zhou, D Chia, D Elashoff, D Akin… - Gut, 2012 - gut.bmj.com
Objective The associations between oral diseases and increased risk of pancreatic cancer
have been reported in several prospective cohort studies. In this study, we measured …

The targets of curcumin

H Zhou, CS Beevers, S Huang - Current drug targets, 2011 - ingentaconnect.com
Curcumin (diferuloylmethane), an orange-yellow component of turmeric or curry powder, is a
polyphenol natural product isolated from the rhizome of the plant Curcuma longa. For …

Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF …

YJ Surh, KS Chun, HH Cha, SS Han, YS Keum… - Mutation Research …, 2001 - Elsevier
A wide array of phenolic substances, particularly those present in edible and medicinal
plants, have been reported to possess substantial anticarcinogenic and antimutagenic …

Phase II trial of curcumin in patients with advanced pancreatic cancer

N Dhillon, BB Aggarwal, RA Newman… - Clinical cancer …, 2008 - aacrjournals.org
Purpose: Pancreatic cancer is almost always lethal, and the only US Food and Drug
Administration–approved therapies for it, gemcitabine and erlotinib, produce objective …

A review of therapeutic effects of curcumin

A Noorafshan… - Current pharmaceutical …, 2013 - ingentaconnect.com
There is a growing interest in herbal medicine. Scientific studies have demonstrated the
beneficial pharmacological effects of curcumin. Curcumin is a bright yellow spice, derived …

Curcumin and cancer: an “old-age” disease with an “age-old” solution

P Anand, C Sundaram, S Jhurani, AB Kunnumakkara… - Cancer letters, 2008 - Elsevier
Cancer is primarily a disease of old age, and that life style plays a major role in the
development of most cancers is now well recognized. While plant-based formulations have …

Genetics and biology of pancreatic ductal adenocarcinoma

AF Hezel, AC Kimmelman, BZ Stanger… - Genes & …, 2006 - genesdev.cshlp.org
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer death in the
United States with a median survival of< 6 mo and a dismal 5-yr survival rate of 3%–5%. The …